Default Category
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Bernd Sterzel en la IV Medizinische Klinik (A)
Hill, Linda A.; Conrad, Melinda B.Case HBS-417S07Leadership and People ManagementDespués de 10 años de funcionamiento de un pequeño laboratorio en la Escuela de Medicina de Yale, el Dr. Bernd R. Sterzel asume el liderazgo de una clínica de nefrología en Nuremberg y Erlangen, Alemania. En sus ambiciosos esfuerzos para transformar la clínica en una institución líder en investigación académica, se encuentra con numerosos retos asociados a la gestión de la asistencia sanitaria en un contexto medicina socializada.Starting at €8.20
-
Bernd Sterzel en la IV Medizinische Klinik (B)
Hill, Linda A.; Conrad, Melinda B.Case HBS-417S08Leadership and People ManagementComplementa el caso (A).Starting at €5.74
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Bernd Sterzel en la IV Medizinische Klinik (C)
Hill, Linda A.; Conrad, Melinda B.Case HBS-417S09Leadership and People ManagementComplementa el caso (A).Starting at €5.74